Pay in 4 interest-free payments of $5.55 Learn more
Ships within 48 hours · Estimated delivery Oct 2 - Oct 7
Liraglutide (Victoza/Saxenda) Approved in 2010, Saxenda (liraglutide) was the first GLP-1 medication approved for weight loss in adults with obesity or overweight with at least one weight-related health issue
Be sure to note daily body temperature at the same time, any new symptoms, or worsening of existing symptoms
PubMed laboratory research record [PMID: 12809743] PubMed record related to this compound for laboratory literature review
GLP-1 users may continue buying indulgent foods, but they are likely to buy less of them
US$ 22.01
US$ 24.03
US$ 28.82
US$ 25.19
US$ 27.56
US$ 28.77
